Meghan Collins

机构：Dell Children's Medical Center of Central Texas, DELL (United States), The University of Texas at Austin · ORCID：0000-0002-6201-9298

发表论文 31 篇 · 总被引 808 次 · h-index 12

代表论文

• Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials (2023 · Nature Medicine · 被引 397)
• Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism (2017 · npj Precision Oncology · 被引 92)
• Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia (2022 · Nature Communications · 被引 63)
• Gilteritinib Inhibits Glutamine Uptake and Utilization in FLT3 -ITD–Positive AML (2021 · Molecular Cancer Therapeutics · 被引 46)
• Novel Strategy for Untargeted Chiral Metabolomics using Liquid Chromatography-High Resolution Tandem Mass Spectrometry (2021 · Analytical Chemistry · 被引 46)
• Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses (2024 · Nature Cancer · 被引 38)